1 active trials 0 recruiting 1 disease areas 2 changes in 30 days
| Phase 2 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2 | ||||
| NCT06487000 | Determine the Dose-dependent Efficacy and Safety of EC-18 in Patients With Moderate to… | Atopic Dermatitis | Not Yet Recruiting | 2026-08-28 |